PCSA Processa Pharmaceuticals, Inc.

-

Processa Pharmaceuticals Reported Earnings

Friday, August 14, 2026 · 12:00 AM ET

Processa Pharmaceuticals (PCSA) reported a loss of $1.19 per share on revenue of $0.00 million for the second quarter ended June 2026. .

Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who have unmet medical need. Processa Pharmaceuticals Inc., formerly known as Heatwurx Inc., is based in HANOVER, United States.

Earnings Whisper Grade
Power Rating
Reported Earnings
($1.19)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth81.0 %
Reported Revenue
Revenue Estimate
Revenue Surprise
Revenue Growth